These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36152139)

  • 1. Are there differences in outcomes by race among women with metastatic triple-negative breast cancer?
    Oppong BA; Rolle AA; Ndumele A; Li Y; Fisher JL; Bhattacharyya O; Adeyanju T; Paskett ED
    Breast Cancer Res Treat; 2022 Nov; 196(2):399-408. PubMed ID: 36152139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
    Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
    Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational Epidemiology: An Integrative Approach to Determine the Interplay Between Genetic Ancestry and Neighborhood Socioeconomic Status on Triple Negative Breast Cancer.
    Goel N; Yadegarynia S; Kwon D; Kesmodel SB; Harbour JW; Kobetz E; Merchant N; Rodriguez DA
    Ann Surg; 2022 Sep; 276(3):430-440. PubMed ID: 35758508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receipt of breast conservation over mastectomy in Black women- does breast cancer subtype matter?
    Oppong BA; Bhattacharyya O; Li Y; Obeng-Gyasi S; Sheppard VB
    J Natl Med Assoc; 2022 Jun; 114(3):298-307. PubMed ID: 35272849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy.
    Woriax HE; Thomas SM; Plichta JK; Rosenberger LH; Botty van den Bruele A; Chiba A; Hwang ES; DiNome ML
    J Clin Oncol; 2024 May; 42(14):1635-1645. PubMed ID: 38394476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer.
    Hercules SM; Hercules JC; Ansari A; Date SAJ; Skeete DHA; Smith Connell SP; Pond GR; Daniel JM
    Cancer; 2020 May; 126(10):2217-2224. PubMed ID: 32154924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival difference between non-Hispanic black and non-Hispanic white women with localized breast cancer: the impact of guideline-concordant therapy.
    Wu X; Richardson LC; Kahn AR; Fulton JP; Cress RD; Shen T; Wolf HJ; Bolick-Aldrich S; Chen VW
    J Natl Med Assoc; 2008 May; 100(5):490-8. PubMed ID: 18507201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of racial differences in clinical outcomes of breast cancer patients receiving neoadjuvant chemotherapy: a single academic center study.
    Sarma M; Perimbeti S; Nasir S; Attwood K; Kapoor A; O'Connor T; Early A; Levine EG; Takabe K; Kalinski P; Ambrosone C; Khoury T; Yao S; Gandhi S
    Breast Cancer Res Treat; 2022 Apr; 192(2):411-421. PubMed ID: 35000093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer.
    Whitaker KD; Wang X; Ascha M; Showalter TN; Lewin HG; Calip GS; Goldstein LJ
    Breast Cancer Res Treat; 2022 Nov; 196(1):163-173. PubMed ID: 36028783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations Between Neighborhood-Level Income and Triple-Negative Breast Cancer in a Majority-Minority Population.
    Hernandez AE; Westrick AC; Stoler J; Kesmodel SB; Pinheiro PS; Figueroa M; Kobetz EN; Rebbeck T; Goel N
    Ann Surg Oncol; 2024 Feb; 31(2):988-996. PubMed ID: 37978105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System.
    Eaglehouse YL; Georg MW; Shriver CD; Zhu K
    JAMA Surg; 2019 Mar; 154(3):e185113. PubMed ID: 30673075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated racial disparities in incidence, clinicopathological features and prognosis of hypopharyngeal squamous carcinoma in the United States.
    Liang Z; Wu M; Wang P; Quan H; Zhao J
    PLoS One; 2023; 18(3):e0282603. PubMed ID: 36928727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.
    Rojas C; Tian C; Powell MA; Chan JK; Bateman NW; Conrads TP; Rocconi RP; Jones NL; Shriver CD; Hamilton CA; Maxwell GL; Casablanca Y; Darcy KM
    Gynecol Oncol; 2020 Apr; 157(1):67-77. PubMed ID: 32029291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population.
    Suresh T; Sharma J; Goel S; Kovac E; Gao Q; Gartrell B
    Clin Genitourin Cancer; 2019 Apr; 17(2):139-144. PubMed ID: 30655076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Black/white differences in treatment and survival among women with stage IIIB-IV breast cancer at diagnosis: a US population-based study.
    Enewold L; Penn DC; Stevens JL; Harlan LC
    Cancer Causes Control; 2018 Jul; 29(7):657-665. PubMed ID: 29860614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities in survival among women with endometrial cancer in an equal access system.
    Park AB; Darcy KM; Tian C; Casablanca Y; Schinkel JK; Enewold L; McGlynn KA; Shriver CD; Zhu K
    Gynecol Oncol; 2021 Oct; 163(1):125-129. PubMed ID: 34325938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in Breast Cancer Death With Adjuvant Chemotherapy Among US Women According to Race, Ethnicity, and the 21-Gene Recurrence Score.
    Huang HC; Calip GS; Weiss J; Simons Y; Gadi VK; Danciu OC; Rauscher GH; Hoskins KF
    J Natl Compr Canc Netw; 2024 Jan; 22(1D):e237077. PubMed ID: 38190799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.
    Cho B; Han Y; Lian M; Colditz GA; Weber JD; Ma C; Liu Y
    JAMA Oncol; 2021 Jul; 7(7):1016-1023. PubMed ID: 33983438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial and Ethnic Disparities in Lung Adenocarcinoma Survival: A Competing-Risk Model.
    Wu X; Wang Y; Lin X; Wang Z; Xu J; Lv W; Hu J
    Clin Lung Cancer; 2020 May; 21(3):e171-e181. PubMed ID: 31787547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Disparities in Survival Outcomes of Patients With Serous Epithelial Ovarian Cancer: A Retrospective Cohort Analysis.
    Shingala K; Stavros S; Parag S; Tercek A; Makhani SS; Bouz A; Galbo A; Chung-Bridges K
    Cureus; 2023 Jan; 15(1):e34389. PubMed ID: 36874646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.